Young man with spinal cord injury regains use of hands and arms after stem cell therapy

Hope is such a fragile thing. We cling to it in bad times. It offers us a sense that we can bear whatever hardships we are facing today, and that tomorrow will be better. Kris Boesen knows all about holding on to hope during bad times. On March 6th of this year he was left … Continue reading Young man with spinal cord injury regains use of hands and arms after stem cell therapy

Clearing the first hurdle: spinal cord injury trial passes safety review

Starting a clinical trial is like taking a step into the unknown. It’s moving a potential therapy out of the lab and testing it in people. To reach this point the researchers have done a lot of work trying to ensure the therapy is safe. But that work was done in the lab, and on … Continue reading Clearing the first hurdle: spinal cord injury trial passes safety review

Stem cell stories that caught our eye: turning on T cells; fixing our brains; progress and trends in stem cells; and one young man’s journey to recover from a devastating injury

A healthy T cell Here are some stem cell stories that caught our eye this past week. Some are groundbreaking science, others are of personal interest to us, and still others are just fun. Directing the creation of T cells. To paraphrase the GOP Presidential nominee, any sane person LOVES, LOVES LOVES their T cells, … Continue reading Stem cell stories that caught our eye: turning on T cells; fixing our brains; progress and trends in stem cells; and one young man’s journey to recover from a devastating injury

Stem cell transplant offers Jake a glimpse of hope

Jake Javier surrounded by friends; Photo courtesy Julie Haener KTVU On Thursday, July 7th, Jake Javier became the latest member of a very select group. Jake underwent a stem cell transplant for a spinal cord injury at Santa Clara Valley Medical Center here in the San Francisco Bay Area. The therapy is part of the … Continue reading Stem cell transplant offers Jake a glimpse of hope

More Good News From CIRM-Funded Spinal Cord Injury Trial

It’s been less than a year since we last reported on the CIRM-funded Asterias Biotherapeutics trial for spinal cord injury (SCI), and we already have more – still preliminary – but good news to share. The company recently released encouraging long-term follow-up results from their original Phase 1 clinical trial that suggest their stem cell … Continue reading More Good News From CIRM-Funded Spinal Cord Injury Trial

New Video: Spinal Cord Injury and a CIRM-Funded Stem Cell-Based Trial

Just 31 years old, Richard Lajara thought he was going to die. On September 9, 2011 he slipped on some rocks at a popular swimming hole and was swept down a waterfall headfirst into a shallow, rocky pool of water. Though he survived, the fall left him paralyzed from the waist down due to a … Continue reading New Video: Spinal Cord Injury and a CIRM-Funded Stem Cell-Based Trial

CIRM-funded clinical trial for spinal cord injury reports promising results

Today, the Menlo Park-based biotech company Asterias Biotherapeutics reported positive results from the first three patients treated in its Phase 1/2a clinical study using stem cell therapy to treat patients with spinal cord injury. This trial is funded by a CIRM Strategic Partnerships Award grant of $14.3 million. Asterias has developed a stem cell therapy … Continue reading CIRM-funded clinical trial for spinal cord injury reports promising results

Spinal cord injury and stem cell research; find out the latest in a Google Hangout

Spinal cord injuries are devastating, leaving the person injured facing a life time of challenges, and placing a huge strain on their family and loved ones who help care for them. The numbers affected are not small. More than a quarter of a million Americans are living with spinal cord injuries and there are more … Continue reading Spinal cord injury and stem cell research; find out the latest in a Google Hangout

FDA gives Asterias green light to start CIRM-funded clinical trial in spinal cord injury

This morning Asterias Biotherapeutics announced that they have been cleared by the Food and Drug Administration (FDA) to start a clinical trial using stem cells to treat spinal cord injury. It’s great news, doubly so as we are funding that trial. You can read more about the trial in a news release we just sent … Continue reading FDA gives Asterias green light to start CIRM-funded clinical trial in spinal cord injury